- Home
- IPHA vs FNKO Comparison
IPHA vs FNKO Comparison
Compare IPHA & FNKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- FNKO
- Stock Information
- Founded
- IPHA 1999
- FNKO 2017
- Country
- IPHA France
- FNKO United States
- Employees
- IPHA N/A
- FNKO N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- FNKO Recreational Games/Products/Toys
- Sector
- IPHA Health Care
- FNKO Consumer Discretionary
- Exchange
- IPHA Nasdaq
- FNKO Nasdaq
- Market Cap
- IPHA 160.1M
- FNKO 170.7M
- IPO Year
- IPHA 2019
- FNKO 2017
- Fundamental
- Price
- IPHA $2.05
- FNKO $3.29
- Analyst Decision
- IPHA Strong Buy
- FNKO Strong Buy
- Analyst Count
- IPHA 1
- FNKO 5
- Target Price
- IPHA $11.00
- FNKO $8.70
- AVG Volume (30 Days)
- IPHA 14.6K
- FNKO 1.4M
- Earning Date
- IPHA 09-17-2025
- FNKO 11-06-2025
- Dividend Yield
- IPHA N/A
- FNKO N/A
- EPS Growth
- IPHA N/A
- FNKO N/A
- EPS
- IPHA N/A
- FNKO N/A
- Revenue
- IPHA $14,839,695.00
- FNKO $970,702,000.00
- Revenue This Year
- IPHA $350.96
- FNKO N/A
- Revenue Next Year
- IPHA $32.92
- FNKO $10.55
- P/E Ratio
- IPHA N/A
- FNKO N/A
- Revenue Growth
- IPHA N/A
- FNKO N/A
- 52 Week Low
- IPHA $1.29
- FNKO $2.22
- 52 Week High
- IPHA $3.51
- FNKO $14.65
- Technical
- Relative Strength Index (RSI)
- IPHA 46.87
- FNKO 47.50
- Support Level
- IPHA $1.93
- FNKO $3.20
- Resistance Level
- IPHA $2.19
- FNKO $3.48
- Average True Range (ATR)
- IPHA 0.11
- FNKO 0.19
- MACD
- IPHA -0.01
- FNKO 0.04
- Stochastic Oscillator
- IPHA 49.66
- FNKO 40.00
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About FNKO Funko Inc.
Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.